Rationale and design of the 500-patient, 3-year, and prospective Vigilant ObservatIon of GlIadeL WAfer ImplaNT registry. [electronic resource]
- CNS oncology 04 2018
- CNS08 p. digital
Antineoplastic Agents--therapeutic use Biomarkers, Tumor--metabolism Carmustine--administration & dosage Central Nervous System Neoplasms--drug therapy Decanoic Acids--administration & dosage Drug Implants Follow-Up Studies Humans Polyesters--administration & dosage Prospective Studies Registries Research Design United States